Trial Profile
Imidazoline-2 Binding Site as a novel target in Huntington's disease: An [11C]BU99008 Positron Emission Tomography study
Status:
Not yet recruiting
Phase of Trial:
Phase IV
Latest Information Update: 28 Jun 2016
Price :
$35
*
At a glance
- Drugs BU 99008 (Primary)
- Indications Huntington's disease
- Focus Therapeutic Use
- 28 Jun 2016 New trial record